Kabeer Aziz - Net Worth and Insider Trading

Kabeer Aziz Net Worth

The estimated net worth of Kabeer Aziz is at least $44 Million dollars as of 2024-11-05. Kabeer Aziz is the Director, 10% Owner of Elevance Health Inc and owns about 2,597,380 shares of Elevance Health Inc (ANTX) stock worth over $41 Million. Kabeer Aziz is also the Director of AN2 Therapeutics Inc and owns about 2,373,500 shares of AN2 Therapeutics Inc (ANTX) stock worth over $3 Million. Details can be seen in Kabeer Aziz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kabeer Aziz has not made any transactions after 2024-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kabeer Aziz

To

Kabeer Aziz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kabeer Aziz owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .

Click here to see the complete history of Kabeer Aziz’s form 4 insider trades.

Insider Ownership Summary of Kabeer Aziz

Ticker Comapny Transaction Date Type of Owner
ANTX AN2 Therapeutics Inc 2024-01-16 director

Kabeer Aziz Latest Holdings Summary

Kabeer Aziz currently owns a total of 2 stocks. Among these stocks, Kabeer Aziz owns 2,597,380 shares of Elevance Health Inc (ANTX) as of March 29, 2022, with a value of $41 Million and a weighting of 94.11%. Kabeer Aziz also owns 2,373,500 shares of AN2 Therapeutics Inc (ANTX) as of January 16, 2024, with a value of $3 Million and a weighting of 5.89%.

Latest Holdings of Kabeer Aziz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANTX Elevance Health Inc 2022-03-29 2,597,380 15.84 41,142,499
ANTX AN2 Therapeutics Inc 2024-01-16 2,373,500 1.09 2,575,248

Holding Weightings of Kabeer Aziz


Kabeer Aziz Form 4 Trading Tracker

According to the SEC Form 4 filings, Kabeer Aziz has made a total of 1 transactions in Elevance Health Inc (ANTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Elevance Health Inc is the acquisition of 166,666 shares on March 29, 2022, which cost Kabeer Aziz around $2 Million.

According to the SEC Form 4 filings, Kabeer Aziz has made a total of 7 transactions in AN2 Therapeutics Inc (ANTX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in AN2 Therapeutics Inc is the sale of 100,000 shares on January 16, 2024, which brought Kabeer Aziz around $2 Million.

Insider Trading History of Kabeer Aziz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kabeer Aziz Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kabeer Aziz Ownership Network

Ownership Network List of Kabeer Aziz

No Data

Ownership Network Relation of Kabeer Aziz

Insider Network Chart

Kabeer Aziz Owned Company Details

What does AN2 Therapeutics Inc do?

Who are the key executives at AN2 Therapeutics Inc?

Kabeer Aziz is the director of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include 10 percent owner Ra Capital Healthcare Fund Lp , 10 percent owner Adjuvant Global Health Technology Fund De, L.p. , and Chief Strategy Officer Kevin Michael Krause .

AN2 Therapeutics Inc (ANTX) Insider Trades Summary

Over the past 18 months, Kabeer Aziz made 7 insider transaction in AN2 Therapeutics Inc (ANTX) with a net sale of 223,880. Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , a net sale of 1,747,316 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 10,000 shares made by Kevin Michael Krause .

In summary, during the past 3 months, insiders sold 3,525,094 shares of AN2 Therapeutics Inc (ANTX) in total and bought 1,500,000 shares, with a net sale of 2,025,094 shares. During the past 18 months, 4,090,725 shares of AN2 Therapeutics Inc (ANTX) were sold and 3,287,778 shares were bought by its insiders, resulting in a net sale of 802,947 shares.

AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AN2 Therapeutics Inc Insider Transactions

No Available Data

Kabeer Aziz Mailing Address

Above is the net worth, insider trading, and ownership report for Kabeer Aziz. You might contact Kabeer Aziz via mailing address: 376 Manhattan Avenue Apt. 3, Brooklyn Ny 11211.